Bringing the fundamentals into focus…
Back to PROCEPT BioRobotics Corporation
How PROCEPT BioRobotics Corporation stacks up
PRCT · against 454 other Healthcare companies listed in US-listed
Growth
78/ 100
Above the middle of the pack.
Ranked #158 of 455 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score52 peers with a growth score of 70–79, including PRCT · Click a bar to see the companies
Why growth scores 78?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 81% of peers. Revenue growth: 22.7% vs peer median 6.1%
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 49.2% vs peer median 5.8%
Metric by metric
Position: dot = PRCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 22.7% | 11.0% | 68% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 49.2% | 11.0% | 85% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PRCT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 158 | 457M USD | 78 | 58 | |
| 158 | 8.7B USD | 78 | 26 | |
| 158 | 31.3B USD | 78 | 63 | |
| 158 | 126.5B USD | 78 | 56 | |
| 158 | 1.1B USD | 78 | 46 | |
| 158 | 474M USD | 78 | 25 | |
| 165 | 301M USD | 77 | 67 | |
| 165 | 7.0B USD | 77 | 63 | |
| 165 | 487M USD | 77 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score